PCN118 Budget IMPACT Analysis of Inotuzumab Ozogamicin for the Treatment of Adults with Relapsed or Refractory B-Cell Precursor ACUTE Lymphoblastic Leukemia in the Netherlands

Dec 1, 2020, 00:00
10.1016/j.jval.2020.08.255
https://www.valueinhealthjournal.com/article/S1098-3015(20)32511-0/fulltext
Title : PCN118 Budget IMPACT Analysis of Inotuzumab Ozogamicin for the Treatment of Adults with Relapsed or Refractory B-Cell Precursor ACUTE Lymphoblastic Leukemia in the Netherlands
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32511-0&doi=10.1016/j.jval.2020.08.255
First page :
Section Title :
Open access? : No
Section Order : 10206
Categories :
Tags :
Regions :
ViH Article Tags :